Immediate Implant Placement With Sticky Tooth Versus Autogenous Tooth Graft In Cases With Labial Plate Dehiscence

Immediate Implant Clinical Trial

Official title:

Evaluation of Soft and Hard Tissue Changes After Immediate Implant Placement With Sticky Tooth Versus Autogenous Tooth Graft In Cases With Labial Plate Dehiscence: A 1-Year Randomized Clinical Trial

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT05891990
• Other study ID #: 2023
• Status: Not yet recruiting
• Phase: N/A
• Start date: October 1, 2023
• Est. completion date: December 30, 2025

Study information

• Verified date: September 2023
• Source: Cairo University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Evaluation of Soft and Hard Tissue Changes After Immediate Implant Placement With Sticky Tooth Versus Autogenous Tooth Graft for management of Cases With Labial Plate Dehiscence

Description:

In patients with labial plate dehiscence in the esthetic zone, there is no difference between the use of tooth-derived granules in combination with platelet-rich fibrin ("sticky tooth") and autogenous tooth graft in conjunction with immediate implant placement in enhancing the amount of bone labial to the implant

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 36
• Est. completion date: December 30, 2025
• Est. primary completion date: October 30, 2025
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 60 Years

Eligibility

Inclusion Criteria:

• Non-restorable teeth in the esthetic zone with a defect of labial bone.
• Teeth with no acute inflammation.
• Patients are free from any systemic condition that may affect the healing.
• Availability of bone apical and palatal to the socket to provide primary stability
• Good oral health.
• Willingness to sign the informed consent form.

Exclusion Criteria:

• Heavy smoker (> 10 cigarettes/day)
• Pregnant females
• Contraindication for Implant surgery.
• Patients with poor oral hygiene.
• Acute inflammation in the site of implantation and adjacent tissue.
• A history of radiotherapy in the head or neck region.
• Patients with systemic diseases like uncontrolled diabetes mellitus, coagulation disorders, alcohol or drug abuse not suitable for implantation

Related Conditions & MeSH terms

• Immediate Implant

Intervention

Procedure:
• immediate implant augmented with sticky tooth
Topical anesthesia will be administered using an infiltration technique. Atraumatic extraction will be done with the aid of periotome and Luxators. The extraction socket will be debrided to remove any residual debris or granulation tissue. Full-thickness midcrestal incision and vertical releasing incision on the distal side will be made, and a vertical releasing incision on the mesial side will be made if necessary. The extraction socket and the labial bone defect will be exposed by buccal and palatal flap reflection. Implant insertion will be performed according to the manufacturer's instruction, and then the implant will be inserted 2mm apical to the alveolar bone crest with adequate primary stability. The gap between the implant and the defect of the facial bone will be filled with the sticky tooth to reach enough buccal bone supported and then will be covered with absorbable barrier collagen membranes. Finally, the flap will be repositioned and sutured.
• immediate implant augmented with autogenous tooth graft
Topical anesthesia will be administered using an infiltration technique. Atraumatic extraction will be done with the aid of periotome and Luxators. The extraction socket will be debrided to remove any residual debris or granulation tissue. Full-thickness midcrestal incision and vertical releasing incision on the distal side will be made, and a vertical releasing incision on the mesial side will be made if necessary. The extraction socket and the labial bone defect will be exposed by buccal and palatal flap reflection. Implant insertion will be performed according to the manufacturer's instruction, and then the implant will be inserted 2mm apical to the alveolar bone crest with adequate primary stability. The gap between the implant and the defect of the facial bone will be filled with the autogenous demineralized dentin graft to reach enough buccal bone supported and then will be covered with collagen membranes. Finally, the flap will be repositioned and sutured.

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Halla Gamal Mohammed Esmail

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Radiographic width of bone labial to the implant	Amount of bone labial to the implant will be measured perpendicular to the vertical line of the implant surface at the implant neck level or the top of the buccal bone (which is regarded as 0 mm), 3 mm and 6 mm apical to the implant neck Each measurement will be recorded at different times	1 year
Secondary	Radiographic horizontal bucco-palatal bone changes	The bucco-palatal width of the alveolar bone will be measured perpendicular to the long axis of the alveolar bone; the 3 measurements will be the coronal width (CW), middle width (MW), and apical width (AW). Each measurement will be recorded at different times	1 year
Secondary	Radiographic vertical bone changes	Vertical bone height will be measured. Measurement will be taken at highest point of the remaining labial/buccal plate of bone using the implant neck as a reference point. Each measurement will be recorded at different times and the difference between pre and post-operative measurements will be determined as the gain in labial/buccal vertical bone dimension	1 year
Secondary	Esthetic evaluation (The pink esthetic score)	The pink esthetic score will be calculated on the parameters defined by (Fürhauser et al. 2005). Clinical photographs will be taken to evaluate peri-implant soft tissue through evaluating seven variables compared to a natural reference tooth including: mesial papilla, distal papilla, soft-tissue level, soft-tissue contour, alveolar process deficiency, soft-tissue color and texture. Using a 0-1-2 scoring system, 0 being the lowest, 2 being the highest value. The maximum achievable PES is 14.	1 year
Secondary	Implant stability	Implant stability will be measured using Ostell which has a scale ranges from 1 to 100, the higher the ISQ the more stability	6 months
Secondary	Gingival Thickness	Gingival thickness will be evaluated 2 mm below the gingival margin with a short needle for and silicon disk stop. The needle will be inserted perpendicular to the mucosal surface, through the soft tissues with light pressure until a hard surface was reached. The silicone disc stop was then mounted in close contact with the gingival tissue surface. The insertion depth was assessed with a digital caliper accurate to the nearest 0.1 mm	1 year
Secondary	Width of the Keratinized Tissue	It will be evaluated from the gingival margin to the mucogingival junction (MGJ). The MGJ was assessed with roll technique	1 year
Secondary	Midfacial recession	Corono-apical distance between the peri-implant soft tissue margin and the cemento-enamel junction (CEJ) of the homologous contralateral tooth	1 year
Secondary	Post-Operative Pain	Pain will be assessed post-surgically using the Visual Analogue Scale (VAS) with numbers from 0 to 10 score zero represented no pain while score 10 represented the worst pain imaginable	7 days
Secondary	Post-Operative patient's Satisfaction	Three Yes or No Questions will be asked to the patient about his overall satisfaction about the procedure; /	1 year
Secondary	Post-operative swelling	Swelling will be assessed post-surgically using the Verbal Rating Scale (VRS) (García et al. 2008): Absent (no swelling),; Slight (intraoral swelling at the operated area),; Moderate (moderate intraoral swelling at the operated area) and; Intense (intensive extraoral swelling extending beyond the operated area)	7 days